← All companies

NCNA

NuCana plc

NCNA Nasdaq Pharmaceutical Preparations EDGAR ↗

$1.35

+0.09 +7.14%

Key statistics

from XBRL data in SEC filings

Market cap

$28.1B

Revenue (TTM)

—

Net income (TTM)

—

EPS (TTM)

—

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

—

Total assets

—

Gross margin

—

52-week range

$1.21 – $10.00

Recent SEC filings

40 most recent

Annual, quarterly & current reports

6-K Jun 8, 2026 6-K Jun 1, 2026 6-K May 14, 2026 6-K May 6, 2026 20-F Mar 19, 2026 6-K Mar 19, 2026 6-K Jan 6, 2026 6-K Dec 17, 2025 6-K Dec 10, 2025 6-K Nov 13, 2025 6-K Nov 5, 2025 6-K Oct 20, 2025 6-K Oct 14, 2025 6-K Sep 5, 2025 6-K Sep 3, 2025 6-K Aug 20, 2025 6-K Aug 1, 2025 6-K Jul 21, 2025 6-K Jul 11, 2025 6-K Jul 9, 2025 6-K Jun 30, 2025 6-K Jun 27, 2025 6-K Jun 20, 2025 6-K FORM 6-K Jun 18, 2025 6-K Jun 5, 2025 6-K Jun 2, 2025 6-K Apr 23, 2025 20-F Mar 20, 2025 6-K Mar 20, 2025 6-K Mar 18, 2025 6-K Feb 10, 2025 6-K Nov 25, 2024 6-K Nov 12, 2024 6-K Oct 1, 2024 6-K Sep 26, 2024 6-K Sep 16, 2024 6-K Aug 29, 2024 6-K Aug 15, 2024 6-K Jun 18, 2024 6-K FORM 6-K May 16, 2024